Cardio Diagnostics Holdings, Inc. (CDIO) community

CDIONasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as CDIOW

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 4/30

$1.89+0.02 (+1.07%)

Close on Nov 13, 2026Market cap $5.59MP/E –Yield –

Community

Notes and questions about Cardio Diagnostics from other investors

No posts about CDIO yet

Discussion is coming to every stock. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Where these numbers come from

Parsed from the XBRL in Cardio Diagnostics's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-30 reverse split on May 13, 2025
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CDIO.

Compare: CDIO vs VRAX · CDIO vs AWHL · CDIO vs PRFX · CDIO vs BDPT · CDIO vs SNTI

Operating margin-42649.8% · median -3808.2%

Net margin-42721.9% · median -5219.2%

Company	Revenue	Growth
AWHL	$170.00K	–
BDPT	$25.56K	+694.1%
CDIO	$15.19K	–
VRAX	–	–
PRFX	–	–
SNTI	–	–

Company

Exchange: Nasdaq
Industry: In Vitro & In Vivo Diagnostic Substances
Fiscal year ends: December 31
Employees: 7
Auditor: Prager Metis CPAs, LLC
SEC CIK: 1870144

Advertisement
300 × 250

See a number that looks wrong?